Scientific Literature Search

Source record

Postbiotics as a therapeutic frontier in Parkinson's disease: Insights into molecular pathways and neuroprotective effects.

Kumari A, Aran KR.

Metab Brain Dis · 2026-09-09

DOI: 10.1007/s11011-026-01978-7PMID: 42714731

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial.

Chen X, Luo K, Liu X, Ye N, Lin W, Liu Z, Cheng X, Huang Z, Xiao Y, Zeng H, Lian Y, Zhang Y, Li M, Huang S, Wang Z, Wang X, Zhang L, Lin H, Zhang Y, Chen Q, Wang D, Ni J, Wang N, Fu Y, Gan S, OSCCAR Investigators.

Brain Stimul · 2026-09-09

DOI: 10.1016/j.brs.2026.103205PMID: 42716220

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Probiotic Spore Inspired Oral Drug Delivery System With Multiple-Barriers-Crossing Ability Modulates Gut-Brain Axis for Parkinson's Disease Therapy.

Feng Q, Mei Y, Zhang J, Sun L, Si B, Zhou H, Xiao H, Liu R, Zhang J, Wang L.

Exploration (Beijing) · 2026-09-09

DOI: 10.1002/exp2.70221PMID: 42719630

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

The Microbiome-Gut-Brain Axis: Decoding the Molecular Dialogue for Next-Generation Neurotherapeutics.

Nadeem MS, Rahman S, Murtaza BN, Al-Zharani M, Afzal M, Nasr FA, Iftikhar S, Chaieb K, Alzarea SI, Kazmi I.

Curr Neuropharmacol · 2026-09-09

DOI: 10.2174/011570159x491341260902051725PMID: 42736672

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

A Comprehensive Review of Chalcones in Dual-Targeted Therapeutics for the Treatment of Parkinson's Disease.

Dhinakaran K, Sivaperuman A, Natarajan R, Kesavan Y, Nagarajan NC, Solomon VR.

Curr Top Med Chem · 2026-09-09

DOI: 10.2174/0115680266472132260829141305PMID: 42736675

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

The Role of cGAS-STING-Driven PANoptosis in Neurodegenerative Diseases and Therapeutic Prospects.

Hou X, Yu W.

Cells · 2026-09-09

DOI: 10.3390/cells15181631PMID: 42782733

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts.

Barbosa R, Bastos P, Rascol O, Corvol JC, Fabienne OM, Brefel-Courbon C, Leung C, Mariani LL, Defebvre L, Carriere N, Giordana C, Heraud C, Laurencin C, Prange S, Remy P, Hopes L, Houeto JL, Prin P, Thiriez C, De Maindreville AD, Benatru I, Corbille AG, di Legge S, Lagha-Boukbiza O, Schneider V, Grimaldi S, Castelnovo G, Tir M, Maltête D, Foubert-Samier A, Marques A, Drapier S, Fabbri M, French NS-Park network.

Neurology · 2026-09-09

DOI: 10.1212/wnl.0000000000218515PMID: 42715510

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation.

Mittal D, Solanki P, Jain GK, Jhawat V, Kesharwani P, Dutt R, Arora S, Singh RP.

3 Biotech · 2026-09-09

DOI: 10.1007/s13205-026-05048-8PMID: 42719214

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Neuroprotective effects of empagliflozin and metformin combined therapy on rotenone induced Parkinsonism in Wistar rats via PI3K and PPARγ modulation.

Mona MM, Borg HM, Ahmed AA, Abass SA, El-Kholy SS.

Sci Rep · 2026-09-08

DOI: 10.1038/s41598-026-68289-wPMID: 42711364

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease.

Ríos-Gallardo A, Herrera-Ramirez D, Bastias-Candia S, Inestrosa NC.

Molecules · 2026-09-08

DOI: 10.3390/molecules31183139PMID: 42796428

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy.

Perales MA, Dietrich J, Gust J, Santomasso B, Rejeski K, Hansen D, Shah NN, Berdeja J, Bishop M, Bleickardt E, Brudno J, Dahiya S, Frey N, Frigault MJ, Gardner R, Ghobadi A, Grupp S, Hamadani M, Jacobson C, Jain MD, Jain T, Komanduri KV, Kumar A, Lim S, Lin Y, Miao H, Neelapu S, Otegbeye F, Park JH, Pasquini M, Patel N, Plautz G, Verdun N, Lee DW, Maus MV, Locke FL.

Transplant Cell Ther · 2026-09-08

DOI: 10.1016/j.jtct.2026.05.020PMID: 42711241

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies.

Boehringer A, Kalia LV, Bloem BR, Kordower JH.

J Parkinsons Dis · 2026-09-07

DOI: 10.1177/1877718x261486172PMID: 42706618

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

20.491 articles found

Postbiotics as a therapeutic frontier in Parkinson's disease: Insights into molecular pathways and neuroprotective effects.

Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial.

Probiotic Spore Inspired Oral Drug Delivery System With Multiple-Barriers-Crossing Ability Modulates Gut-Brain Axis for Parkinson's Disease Therapy.

The Microbiome-Gut-Brain Axis: Decoding the Molecular Dialogue for Next-Generation Neurotherapeutics.

A Comprehensive Review of Chalcones in Dual-Targeted Therapeutics for the Treatment of Parkinson's Disease.

The Role of cGAS-STING-Driven PANoptosis in Neurodegenerative Diseases and Therapeutic Prospects.

Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts.

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation.

Neuroprotective effects of empagliflozin and metformin combined therapy on rotenone induced Parkinsonism in Wistar rats via PI3K and PPARγ modulation.

Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease.

ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy.

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies.

Filters